KRAS and cancer: Finally, we investigated the impact of SNIPE on cell survival and genotype after targeting disease alleles in the heterozygous cancer cell lines RD-ES (p53 R273C), HT-29 (APC E853*), and HuCC-T1 (KRAS G12D).